XML 28 R19.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Share Based Compensation | 6 Months Ended
--- | ---
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract] |
Share Based Compensation | 11. Share Based Compensation Omnibus Incentive Plan At the 2019 Annual Shareholders Meeting of Thunder Bridge, the shareholders considered and approved the 2019 Omnibus Incentive Plan (the “Incentive Plan”) which resulted in the reservation of 7,326,728 shares of Class A common stock for issuance thereunder. The Incentive Plan initially became effective immediately upon the closing of the Business Combination. In June 2022, the Incentive Plan was amended and restated to reserve an additional 6,500,000 shares of Class A common stock for issuance thereunder. In May 2024, the Incentive Plan was again amended and restated to reserve an additional 8,400,000 shares of Class A common stock for issuance thereunder. Under this plan, the Company currently has four types of share-based compensation awards outstanding: performance stock units (“PSUs”), restricted stock awards (“RSAs”), restricted stock units (“RSUs”) and performance-based stock options (“PSOs”). Share-Based Awards The following table summarizes share-based compensation expense and the related income tax benefit recognized for the Company’s share-based compensation awards. Share-based compensation expenses are recorded within Selling, general and administrative in the Company’s Condensed Consolidated Statement of Operations.
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
($ in millions) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Share-based compensation expense |  | $ | 5.7 |  |  | $ | 6.5 |  |  | $ | 12.0 |  |  | $ | 10.6 |
Income tax benefit |  |  | 0.1 |  |  |  | 0.2 |  |  |  | 2.3 |  |  |  | 1.3 |
Activity for RSAs for the six months ended June 30, 2024 was as follows:
|  | Class A Common Stock |  |  | Weighted Average Grant Date Fair Value |
Unvested at December 31, 2023 |  |  | 3,550,365 |  |  | $ | 9.26 |
Granted |  |  | 1,858,554 |  |  |  | 8.00 |
Forfeited (1) |  |  | 436,239 |  |  |  | 9.92 |
Vested |  |  | 703,836 |  |  |  | 10.78 |
Unvested at June 30, 2024 |  |  | 4,268,844 |  |  | $ | 8.39 |
(1) The forfeited shares include shares forfeited as a result of employee terminations and shares withheld to satisfy employees’ tax withholding and payment obligations in connection with the vesting of restricted stock awards under the Incentive Plan during the six months ended June 30, 2024; further, these forfeited shares are added back to the amount of shares available for grant under the Incentive Plan. Activity for RSUs for the six months ended June 30, 2024 was as follows:
|  | Class A Common Stock |  |  | Weighted Average Grant Date Fair Value |
Unvested at December 31, 2023 |  |  | 171,384 |  |  | $ | 7.41 |
Granted |  |  | 130,923 |  |  |  | 9.70 |
Forfeited |  |  | — |  |  |  | — |
Vested |  |  | 171,384 |  |  |  | 7.41 |
Unvested at June 30, 2024 |  |  | 130,923 |  |  | $ | 9.70 |
On May 30, 2024, the Company’s Compensation Committee approved two PSU grant agreements, with one vesting based on relative total stock return (“TSR PSUs”) and one vesting based on adjusted EBITDA growth (“EBITDA PSUs”). TSR PSUs are based on a performance condition, such that the Company’s total shareholder return relative to a comparator group for the applicable performance period determines the number of shares (if any) that is ultimately issued upon vesting. The grant date fair value of TSR PSUs is estimated using the Monte Carlo simulation. Compensation expense of TSR PSUs generally is recognized on a straight-line basis over the applicable performance period. EBITDA PSUs are based on a performance condition, such that the growth of the Company’s adjusted EBITDA during each fiscal year within the applicable performance period determines the number of shares (if any) that is ultimately issued upon vesting. The grant date fair value of EBITDA PSUs is based on the quoted market value of the Company’s Class A common stock on the grant date. As the Company determines that the performance condition associated with EBITDA PSUs is probable, the attributable compensation expense generally is recognized on a straight-line basis over the applicable performance period. If, in the future, it is determined that achieving the performance condition related to EBITDA PSUs is improbable, the Company would reverse any compensation expense recognized to date associated with EBITDA PSUs. Activity for PSUs for the six months ended June 30, 2024 was as follows:
|  | Class A Common Stock (1) |  |  | Weighted Average Grant Date Fair Value |
Unvested at December 31, 2023 |  |  | 1,482,791 |  |  | $ | 10.88 |
Granted |  |  | 762,583 |  |  |  | 13.03 |
Forfeited |  |  | — |  |  |  | — |
Vested |  |  | — |  |  |  | — |
Unvested at June 30, 2024 |  |  | 2,245,374 |  |  | $ | 11.61 |
(1) Represent shares to be paid out at 100% target level. For PSUs, RSAs, and RSUs vested during the six months ended June 30, 2024, the total fair value, based upon the Company’s Class A common stock price at the date vested, was $11.3 million. Unrecognized compensation expense related to unvested PSUs, RSAs and RSUs was $38.2 million at June 30, 2024, which is expected to be recognized as expense over the weighted-average period of 2.0 years. Stock Options Activity for PSOs for the six months ended June 30, 2024 was as follows:
|  | Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (in years) |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2023 |  |  | 1,148,822 |  |  |  | 6.13 |  |  |  | 7.0 |  |  | $ | 2,768,661 |
Granted |  |  | — |  |  |  | — |  |  |  |  |  |  |
Forfeited |  |  | — |  |  |  | — |  |  |  |  |  |  |
Exercised |  |  | — |  |  |  | — |  |  |  |  |  |  |
Outstanding at June 30, 2024 |  |  | 1,148,822 |  |  | $ | 6.13 |  |  |  | 7.0 |  |  | $ | 5,089,281 |
Options vested and exercisable at June 30, 2024 |  |  | 353,354 |  |  | $ | 6.13 |  |  |  | 7.0 |  |  | $ | 1,565,358 |
The Company recognized compensation expense for PSOs of $0.2 million and $0.6 million during the three and six months ended June 30, 2024, respectively. The Company recognized compensation expense for PSOs of $0.4 million and $0.5 million during the three and six months ended June 30, 2023, respectively. Unrecognized compensation expense related to outstanding PSOs was $0.9 million at June 30, 2024, which is expected to be recognized as expense over the weighted-average period of 1.3 years. The weighted average grant date fair value of PSOs granted during the six months ended June 30, 2023 was $2.61. Fair value was estimated on the date of grant using Monte Carlo simulation with the following weighted average assumptions:
|  | Six Months Ended June 30, 2023 |
Risk-free interest rate |  |  | 3.42 | %
Expected volatility |  |  | 52.82 | %
Dividend yield |  |  | 0 | %
Expected term (in years) |  |  | 4.5 |
The risk-free interest rate was based on the yield of a zero-coupon U.S. Treasury security with a maturity equal to the contractual term of seven years. The assumption on expected volatility was based on the average of historical peer group volatilities using daily prices. The dividend yield assumption was determined as 0% since the Company pays no dividends. Expected term was based on the simplified method outlined in Staff Accounting Bulletin No. 14, Share-Based Payment due to the fact that Company does not have sufficient historical data upon which to estimate an expected term. Given that the Company’s Class A common stock has been publicly traded for less than seven years, the Company believes that the simplified method is an applicable methodology to estimate the expected term of the options as of the grant date. Employee Stock Purchase Plan On August 18, 2021, the Company’s stockholders approved the Repay Holdings Corporation 2021 Employee Stock Purchase Plan (the “ESPP”). The purpose of the ESPP is to provide eligible employees with the opportunity to purchase the Company’s Class A common stock through accumulated payroll deductions. A total of 1,000,000 shares of the Company’s Class A common stock are available for issuance under the ESPP. Under the ESPP, participants are offered the right to purchase shares of the Company’s Class A common stock at a discount during a series of offering periods. The length of the offering periods under the ESPP will be determined by the administrator and may be up to twenty-seven months long.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//505/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration